S&P 500   3,355.32 (+1.72%)
DOW   27,691.84 (+1.91%)
QQQ   275.06 (+1.29%)
AAPL   113.73 (+1.29%)
MSFT   208.95 (+0.54%)
FB   256.15 (+0.52%)
GOOGL   1,457.75 (+1.30%)
AMZN   3,144.00 (+1.58%)
TSLA   419.45 (+2.97%)
NVDA   514.69 (-0.05%)
BABA   275.99 (+1.81%)
CGC   14.35 (+1.27%)
GE   6.26 (+2.45%)
MU   49.08 (-0.12%)
AMD   78.46 (+0.51%)
T   28.63 (+2.10%)
F   6.72 (+3.23%)
ACB   4.87 (-3.56%)
GILD   62.60 (+0.56%)
NFLX   483.11 (+0.05%)
DIS   126.33 (+1.88%)
BA   166.86 (+6.94%)
BAC   24.22 (+3.11%)
S&P 500   3,355.32 (+1.72%)
DOW   27,691.84 (+1.91%)
QQQ   275.06 (+1.29%)
AAPL   113.73 (+1.29%)
MSFT   208.95 (+0.54%)
FB   256.15 (+0.52%)
GOOGL   1,457.75 (+1.30%)
AMZN   3,144.00 (+1.58%)
TSLA   419.45 (+2.97%)
NVDA   514.69 (-0.05%)
BABA   275.99 (+1.81%)
CGC   14.35 (+1.27%)
GE   6.26 (+2.45%)
MU   49.08 (-0.12%)
AMD   78.46 (+0.51%)
T   28.63 (+2.10%)
F   6.72 (+3.23%)
ACB   4.87 (-3.56%)
GILD   62.60 (+0.56%)
NFLX   483.11 (+0.05%)
DIS   126.33 (+1.88%)
BA   166.86 (+6.94%)
BAC   24.22 (+3.11%)
S&P 500   3,355.32 (+1.72%)
DOW   27,691.84 (+1.91%)
QQQ   275.06 (+1.29%)
AAPL   113.73 (+1.29%)
MSFT   208.95 (+0.54%)
FB   256.15 (+0.52%)
GOOGL   1,457.75 (+1.30%)
AMZN   3,144.00 (+1.58%)
TSLA   419.45 (+2.97%)
NVDA   514.69 (-0.05%)
BABA   275.99 (+1.81%)
CGC   14.35 (+1.27%)
GE   6.26 (+2.45%)
MU   49.08 (-0.12%)
AMD   78.46 (+0.51%)
T   28.63 (+2.10%)
F   6.72 (+3.23%)
ACB   4.87 (-3.56%)
GILD   62.60 (+0.56%)
NFLX   483.11 (+0.05%)
DIS   126.33 (+1.88%)
BA   166.86 (+6.94%)
BAC   24.22 (+3.11%)
S&P 500   3,355.32 (+1.72%)
DOW   27,691.84 (+1.91%)
QQQ   275.06 (+1.29%)
AAPL   113.73 (+1.29%)
MSFT   208.95 (+0.54%)
FB   256.15 (+0.52%)
GOOGL   1,457.75 (+1.30%)
AMZN   3,144.00 (+1.58%)
TSLA   419.45 (+2.97%)
NVDA   514.69 (-0.05%)
BABA   275.99 (+1.81%)
CGC   14.35 (+1.27%)
GE   6.26 (+2.45%)
MU   49.08 (-0.12%)
AMD   78.46 (+0.51%)
T   28.63 (+2.10%)
F   6.72 (+3.23%)
ACB   4.87 (-3.56%)
GILD   62.60 (+0.56%)
NFLX   483.11 (+0.05%)
DIS   126.33 (+1.88%)
BA   166.86 (+6.94%)
BAC   24.22 (+3.11%)
Log in
OTCMKTS:VREOF

Vireo Health International Price Target, Predictions & Analyst Ratings

$0.96
0.00 (-0.08 %)
(As of 09/25/2020 08:10 PM ET)
Add
Compare
Today's Range
$0.92
Now: $0.96
$1.00
50-Day Range
$0.54
MA: $0.74
$1.05
52-Week Range
$0.20
Now: $0.96
$1.76
Volume51,083 shs
Average Volume169,524 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Vireo Health International (OTCMKTS:VREOF) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Vireo Health International in the last 12 months. Their average twelve-month price target is $1.33, predicting that the stock has a possible upside of 37.42%. The high price target for VREOF is $2.00 and the low price target for VREOF is $0.65. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
VREOF Consensus Rating: BuyBuyBuyN/A
VREOF Consensus Rating Score: 2.672.502.50N/A
VREOF Analyst Ratings: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
VREOF Consensus Price Target: $1.33$1.33$1.20N/A
VREOF Price Target Upside: 37.42% upside120.83% upside103.39% upsideN/A

Vireo Health International (OTCMKTS:VREOF) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Vireo Health International (OTCMKTS:VREOF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
9/16/2020Craig HallumInitiated CoverageBuy
8/27/2020Canaccord GenuityReiterated RatingBuy$2.00
5/15/2020Eight CapitalDowngradeBuy ➝ Neutral$0.65
(Data available from 9/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.